Latest Asx News

Pantera Lithium has completed a detailed 3D geological model confirming the potential of its Arkansas lithium brine project and raised over $2 million to fund exploration despite initial drilling setbacks.

Centrex Limited corrects its corporate presentation title to January 2025 and details progress on its Ardmore Phosphate Project Stage 1.5 Expansion, supported by a $10.4 million Entitlement Offer aimed at boosting production capacity and financial stability.

BKI Investment Company Limited reported a modest rise in ordinary revenue and declared a 1% higher interim dividend despite a challenging economic backdrop and softer special investment income.

BKI Investment Company Limited has announced a fully franked ordinary dividend of AUD 0.039 per share for the half-year ending December 31, 2024, payable on February 28, 2025. The company’s Dividend Reinvestment Plan remains active, offering shareholders flexibility.

Centrex Limited has initiated a $10.4 million Entitlement Offer to fund the critical Stage 1.5 Expansion of its Ardmore Phosphate Project, aiming to boost production capacity to 625ktpa. The company highlights the pivotal role of this capital raise in securing operational continuity amid notable financial and logistical risks.

Murray Cod Australia Limited has announced a 10-for-1 security consolidation affecting all ordinary shares and options, aiming to simplify its capital structure ahead of resumed trading in February 2025.

Charter Hall Wholesale Management Limited has secured majority control of Hotel Property Investments (HPI) with a 63.7% voting stake and the HPI board now recommends acceptance of the all-cash takeover offer valued at $3.752 per security.

Traffic Technologies Limited has landed a significant $3 million contract to supply smart LED streetlights to the City of Sydney, with potential extensions pushing the deal’s value to $5 million over nine years.

Energy Transition Minerals Ltd has successfully raised A$9.35 million through a strategic share placement, bolstering its financial position to advance the Kvanefjeld Rare Earths Project in Greenland and attracting new international institutional investors.

Recce Pharmaceuticals has successfully dosed all patients in its Phase II trial of RECCE® 327 topical gel for acute bacterial skin infections, showing encouraging preliminary efficacy and safety data. The company is preparing for pivotal Phase III trials in Australia and Indonesia, targeting a significant global market opportunity.

Fulcrum Lithium Ltd has successfully completed its IPO, raising $9.7 million, and commenced drilling at its Alkali Flats lithium project in Nevada, marking a significant step in its exploration journey.

Noronex Limited reports robust copper-silver assay results from its Fiesta Project drilling in Namibia, revealing extensive mineralisation over 4.5 kilometres and promising new step-out intercepts. The company advances towards a potentially transformative copper discovery in the Kalahari Copper Belt.